The baseline levels of six proteins were identified as potentially useful in distinguishing MS and controls, which included CAMK2A, CNTNAP4, IGLON5, RTN4RL2, SEZ6L and TMEM132D. The gene discussed is CNTNAP4; the disease is myeloid sarcoma.